Tagged with Drug

Gilead CEO Named New PhRMA Board Chair; Inherits a Litany of Challenges
2023: A Pivotal Year for SwissMedic
EMA 2023 New Drug Approvals: Cancer at the Forefront
How Today’s Specialty Medicines are Driving the Future of Engagement
AI-Driven Drug Discovery: Finally Living up to its Promise?
Merck’s IRA Lawsuit Comes Under Fire from Own Shareholders
AbbVie Withdraws from PhRMA & BIO after US Drug Pricing Defeat
Clinical Trial Diversity: Patient Engagement, Remote Participation & Industry Buy-In
Drugs Approved by the Chinese NMPA in 2021
Fabrizio Chines – President & CEO, SIFI
Key Features of Orphan Drug Registration in Singapore, Malaysia, Philippines, and Vietnam
What Can Brazil’s Pharma Industry Learn from India?
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here